MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells
With a prevalence of 12.5% of all new cancer cases annually, breast cancer stands as the most common form of cancer worldwide. The current therapies utilized for breast cancer are constrained and ineffective in addressing the condition. siRNA-based gene silencing is a promising method for treating b...
Main Authors: | Rajesh Salve, Niladri Haldar, Aazam Shaikh, Rajkumar Samanta, Devyani Sengar, Surajit Patra, Virendra Gajbhiye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2024.1383495/full |
Similar Items
-
Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery
by: Mahavir Narwade, et al.
Published: (2023-05-01) -
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics
by: Kavita R. Gajbhiye, et al.
Published: (2023-10-01) -
Up-Link Asynchronous SCMA Low Complexity Signal Detection Algorithm
by: Zhen-yu LEI, et al.
Published: (2021-08-01) -
Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept
by: Leila Fotooh Abadi, et al.
Published: (2023-01-01) -
Wild type, dEX3 and 2B survivin isoforms localize to the tumor cell plasma membrane, are secreted in exosomes, and interact with extracellular tubulin
by: Sheila Figel, et al.
Published: (2021-12-01)